Company Affymax, Inc. Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2012 | Weight | 2013 | Weight | Delta |
---|---|---|---|---|---|
Collaboration
99.6
%
| - | - | 1 | 99.6 % | - |
License and Royalty
0.4
%
| - | - | 0 | 0.4 % | - |
Sales per region
USD in Million | 2012 | Weight | 2013 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 94 | 100.0 % | 1 | 100.0 % | -98.55% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,490,095 | 37,490,095 ( 100.00 %) | 0 | 100.00 % |
Company contact information
![address Affymax, Inc.](https://cdn.zonebourse.com/static/address/39433.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+21.85% | 46.93B | |
+37.63% | 39.08B | |
-8.05% | 38.48B | |
+29.04% | 31.01B | |
-13.75% | 26.14B | |
+10.65% | 25.88B | |
+38.43% | 12.53B | |
-6.92% | 11.36B | |
-12.29% | 10.65B |
- Stock Market
- Equities
- AFFY Stock
- Stock
- Company Affymax, Inc.